MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $20,953 | +479.6% | 4,677 | +200.2% | 0.00% | – |
| Q4 2023 | $3,615 | -44.3% | 1,558 | -69.5% | 0.00% | – |
| Q3 2023 | $6,485 | -61.4% | 5,106 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $16,799 | +5.2% | 5,106 | +31.5% | 0.00% | 0.0% |
| Q1 2023 | $15,963 | -58.1% | 3,884 | -40.3% | 0.00% | -50.0% |
| Q4 2022 | $38,137 | +18.6% | 6,508 | +36.8% | 0.00% | 0.0% |
| Q3 2022 | $32,164 | +46.3% | 4,758 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $21,982 | +15.8% | 4,758 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $18,984 | -67.9% | 4,758 | -50.0% | 0.00% | 0.0% |
| Q4 2021 | $59,227 | -58.0% | 9,522 | -36.3% | 0.00% | -50.0% |
| Q3 2021 | $140,997 | -47.5% | 14,952 | -24.4% | 0.00% | -50.0% |
| Q2 2021 | $268,504 | +13.6% | 19,772 | +35.4% | 0.00% | 0.0% |
| Q1 2021 | $236,309 | -43.9% | 14,605 | -7.8% | 0.00% | -33.3% |
| Q4 2020 | $421,343 | +46.1% | 15,834 | +2.2% | 0.01% | +20.0% |
| Q3 2020 | $288,349 | -14.1% | 15,486 | +7.9% | 0.01% | -16.7% |
| Q2 2020 | $335,767 | +1009.5% | 14,349 | +176.4% | 0.01% | +500.0% |
| Q1 2020 | $30,264 | – | 5,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |